StonvexLoading…
StonvexStonvexStonvexCore line items from CG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.78B | $5.43B | $2.96B | $4.44B |
Operating Income | $1.16B | $1.39B | $-600.90M | $1.57B |
Net Income | $808.70M | $1.02B | $-608.40M | $1.23B |
EPS (Diluted) | $2.18 | $2.77 | $-1.68 | $3.35 |
Total Assets | $29.12B | $23.10B | $21.18B | $21.40B |
Total Liabilities | $22.06B | $16.76B | $15.39B | $14.58B |
Cash & Equivalents | $1.97B | $1.27B | $1.44B | $1.36B |
Free Cash Flow OCF − CapEx | $-3.37B | $-837.20M | $138.30M | $-419.90M |
Shares Outstanding | 357.37M | 357.18M | 361.33M | 362.30M |